Sep 14th
Aug 30th
Dupixent® (dupilumab) Pivotal Trial Meets All Primary and Secondary Endpoints Becoming First Biologic Medicine to Significantly Reduce Signs and Symptoms of Moderate-to-severe Atopic Dermatitis in Children as Young as 6 Months
Scientific trailblazers
Our Clinical Pipeline
Our story is unusual, with remarkable consistency of leadership and purpose in our efforts to accelerate the drug discovery and development process.
Through responsible business practices and with the highest standards of integrity,
we rise to any challenge with characteristic drive and a focus on scientific innovation.
We’re applying our novel technologies to respond swiftly to public health infectious disease outbreaks like Ebola, MERS and COVID-19.
Alumni of Regeneron’s STEM programs and competitions have won National Medals of Science, Fields Medals and Nobel Prizes. Our goal? Equip the next generation to keep the accolades, and the groundbreaking science, coming.
Sequencing the next million
The Regeneron Genetics Center® is working to solve the body’s most complex mysteries, because curiosity is in our genes.
Citizens of science
COVID-19 ANTIBODY PROGRAM
Back to top
You are now leaving Regeneron.com. The site you are about to visit is maintained by a third party who is solely responsible for its content. We encourage you to read the privacy policy of every website you visit.


How do you spark a scientific revolution in genomics? Pair lightning-fast, computational pattern recognition with an unprecedented amount of health data. The Regeneron Genetics Center is leveraging the power of artificial intelligence and machine learning to do just that. 